LOVELAND PRODUCTS MSO WITH LECI-TECH SPRAY ADJUVANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

loveland products mso with leci-tech spray adjuvant

loveland products inc - methyl esters of vegetable oil - emulsifiable concentrate - methyl esters of vegetable oil oil-plant active 630.0 g/l - adjuvant

Multi Parameter Drugs of Abuse Rapid Test Tanzania - English - Tanzania Medicinces & Medical Devices Authority

multi parameter drugs of abuse rapid test

rapid labs ltd, united kingdom - multi parameter drugs of abuse rapid test -

NovoRapid European Union - English - EMA (European Medicines Agency)

novorapid

novo nordisk a/s - insulin aspart - diabetes mellitus - drugs used in diabetes - novorapid is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Loveland Products Weather Gard Complete Adjuvant Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

loveland products weather gard complete adjuvant

loveland products inc - soyal phospholipids - emulsifiable concentrate - soyal phospholipids ungrouped active 495.0 g/l - adjuvant

MADOPAR RAPID 62.5 dispersible 62.5mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

madopar rapid 62.5 dispersible 62.5mg tablet bottle

roche products pty ltd - benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg); levodopa, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; pregelatinised maize starch; citric acid; microcrystalline cellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

MADOPAR RAPID 125 Dispersible 125mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

madopar rapid 125 dispersible 125mg tablet bottle

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.